The association between TP53 Arg72pro polymorphism and non-melanoma skin cancer risk: A meta-analysis including 7,107 subjects
Background: The p53 gene is a critical molecular in the protection of cells from DNA damage due to Ultraviolet (UV) exposure, and TP53 mutation is very common in non-melanoma skin cancer. Objectives: To assess the association between the TP53 Arg72Pro polymorphism and non-melanoma skin cancer (NMSC)...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
| Series: | Indian Journal of Dermatology |
| Subjects: | |
| Online Access: | http://www.e-ijd.org/article.asp?issn=0019-5154;year=2013;volume=58;issue=3;spage=175;epage=180;aulast=Yang |
| _version_ | 1818671190088089600 |
|---|---|
| author | Xueling Yang Baohong Yang Ya Liu Shanshan Xu Bo Li |
| author_facet | Xueling Yang Baohong Yang Ya Liu Shanshan Xu Bo Li |
| author_sort | Xueling Yang |
| collection | DOAJ |
| description | Background: The p53 gene is a critical molecular in the protection of cells from DNA damage due to Ultraviolet (UV) exposure, and TP53 mutation is very common in non-melanoma skin cancer. Objectives: To assess the association between the TP53 Arg72Pro polymorphism and non-melanoma skin cancer (NMSC) risk. Methods: We performed this meta-analysis with 13 case-control studies involving 3,520 cases and 3,587 controls. Results: Our meta-analysis showed that TP53 Arg72Pro polymorphism was not associated with non-melanoma skin cancer susceptibility in overall population.(for Arg/Arg vs. Pro/Pro: OR 0.98, 95% CI 0.80-1.19; for Arg/Pro vs. Pro/Pro: OR 0.99, 95% CI 0.84-1.17; for the recessive model Arg/Arg vs. Arg/Pro + Pro/Pro: OR 1.10, 95% CI 0.89-1.35; for the dominant model Arg/Arg + Arg/Pro vs. Pro/Pro: OR 1.00, 95% CI 0.85-1.18). We also detected no effect of this polymorphism on any subtype of non-melanoma skin cancer, such as squamous cell carcinoma (SCC), and basal cell carcinoma (BCC). Furthermore, no significant association in any subgroup was detected in stratified analyses according to ethnicity. However, in the stratified analysis by sample collection resources, Arg/Arg carriers from tumor tissue subgroup had 3.42 times risk of cancer (95% CI, 1.19 to 9.84) as compared with the variant type Pro/Pro in NMSC. Conclusions: TP53 Arg72Pro polymorphism may have little involvement in the pathogenesis of NMSC, regardless of type, including SCC, and BCC. |
| first_indexed | 2024-12-17T07:20:03Z |
| format | Article |
| id | doaj.art-54c17fb639b240be97fd2853d7ae4c03 |
| institution | Directory Open Access Journal |
| issn | 0019-5154 1998-3611 |
| language | English |
| last_indexed | 2024-12-17T07:20:03Z |
| publishDate | 2013-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Indian Journal of Dermatology |
| spelling | doaj.art-54c17fb639b240be97fd2853d7ae4c032022-12-21T21:58:46ZengWolters Kluwer Medknow PublicationsIndian Journal of Dermatology0019-51541998-36112013-01-0158317518010.4103/0019-5154.110823The association between TP53 Arg72pro polymorphism and non-melanoma skin cancer risk: A meta-analysis including 7,107 subjectsXueling YangBaohong YangYa LiuShanshan XuBo LiBackground: The p53 gene is a critical molecular in the protection of cells from DNA damage due to Ultraviolet (UV) exposure, and TP53 mutation is very common in non-melanoma skin cancer. Objectives: To assess the association between the TP53 Arg72Pro polymorphism and non-melanoma skin cancer (NMSC) risk. Methods: We performed this meta-analysis with 13 case-control studies involving 3,520 cases and 3,587 controls. Results: Our meta-analysis showed that TP53 Arg72Pro polymorphism was not associated with non-melanoma skin cancer susceptibility in overall population.(for Arg/Arg vs. Pro/Pro: OR 0.98, 95% CI 0.80-1.19; for Arg/Pro vs. Pro/Pro: OR 0.99, 95% CI 0.84-1.17; for the recessive model Arg/Arg vs. Arg/Pro + Pro/Pro: OR 1.10, 95% CI 0.89-1.35; for the dominant model Arg/Arg + Arg/Pro vs. Pro/Pro: OR 1.00, 95% CI 0.85-1.18). We also detected no effect of this polymorphism on any subtype of non-melanoma skin cancer, such as squamous cell carcinoma (SCC), and basal cell carcinoma (BCC). Furthermore, no significant association in any subgroup was detected in stratified analyses according to ethnicity. However, in the stratified analysis by sample collection resources, Arg/Arg carriers from tumor tissue subgroup had 3.42 times risk of cancer (95% CI, 1.19 to 9.84) as compared with the variant type Pro/Pro in NMSC. Conclusions: TP53 Arg72Pro polymorphism may have little involvement in the pathogenesis of NMSC, regardless of type, including SCC, and BCC.http://www.e-ijd.org/article.asp?issn=0019-5154;year=2013;volume=58;issue=3;spage=175;epage=180;aulast=YangMeta-analysisnon-melanoma skin cancerTP53 Arg72Pro polymorphism |
| spellingShingle | Xueling Yang Baohong Yang Ya Liu Shanshan Xu Bo Li The association between TP53 Arg72pro polymorphism and non-melanoma skin cancer risk: A meta-analysis including 7,107 subjects Indian Journal of Dermatology Meta-analysis non-melanoma skin cancer TP53 Arg72Pro polymorphism |
| title | The association between TP53 Arg72pro polymorphism and non-melanoma skin cancer risk: A meta-analysis including 7,107 subjects |
| title_full | The association between TP53 Arg72pro polymorphism and non-melanoma skin cancer risk: A meta-analysis including 7,107 subjects |
| title_fullStr | The association between TP53 Arg72pro polymorphism and non-melanoma skin cancer risk: A meta-analysis including 7,107 subjects |
| title_full_unstemmed | The association between TP53 Arg72pro polymorphism and non-melanoma skin cancer risk: A meta-analysis including 7,107 subjects |
| title_short | The association between TP53 Arg72pro polymorphism and non-melanoma skin cancer risk: A meta-analysis including 7,107 subjects |
| title_sort | association between tp53 arg72pro polymorphism and non melanoma skin cancer risk a meta analysis including 7 107 subjects |
| topic | Meta-analysis non-melanoma skin cancer TP53 Arg72Pro polymorphism |
| url | http://www.e-ijd.org/article.asp?issn=0019-5154;year=2013;volume=58;issue=3;spage=175;epage=180;aulast=Yang |
| work_keys_str_mv | AT xuelingyang theassociationbetweentp53arg72propolymorphismandnonmelanomaskincancerriskametaanalysisincluding7107subjects AT baohongyang theassociationbetweentp53arg72propolymorphismandnonmelanomaskincancerriskametaanalysisincluding7107subjects AT yaliu theassociationbetweentp53arg72propolymorphismandnonmelanomaskincancerriskametaanalysisincluding7107subjects AT shanshanxu theassociationbetweentp53arg72propolymorphismandnonmelanomaskincancerriskametaanalysisincluding7107subjects AT boli theassociationbetweentp53arg72propolymorphismandnonmelanomaskincancerriskametaanalysisincluding7107subjects AT xuelingyang associationbetweentp53arg72propolymorphismandnonmelanomaskincancerriskametaanalysisincluding7107subjects AT baohongyang associationbetweentp53arg72propolymorphismandnonmelanomaskincancerriskametaanalysisincluding7107subjects AT yaliu associationbetweentp53arg72propolymorphismandnonmelanomaskincancerriskametaanalysisincluding7107subjects AT shanshanxu associationbetweentp53arg72propolymorphismandnonmelanomaskincancerriskametaanalysisincluding7107subjects AT boli associationbetweentp53arg72propolymorphismandnonmelanomaskincancerriskametaanalysisincluding7107subjects |